REPEAT: Rocket Doctor Scales Rapidly in Alberta, Strengthening Physician Independence and Expanding Healthcare Access
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF) announces significant growth of Rocket Doctor's virtual healthcare platform in Alberta. The platform has served over 71,000 Albertans, with 35% from communities under 25,000 population.
Key achievements include:
- 112% increase in patient visits year-over-year, serving 36,779 patients
- 218% growth in new physicians joining the platform, with 48 new doctors onboard
- 4.4-star Google rating from over 2,400 reviews
Rocket Doctor's model enables independent physicians to operate efficiently while covered under Alberta's provincial health insurance. The company plans to integrate AI-driven tools and expand its services across Canada. Treatment.com AI Inc. has a definitive share purchase agreement dated February 11, 2025, to acquire Rocket Doctor Inc.
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF) annuncia una crescita significativa della piattaforma di telemedicina Rocket Doctor in Alberta. La piattaforma ha servito oltre 71.000 Albertani, di cui il 35% proviene da comunità con meno di 25.000 abitanti.
I risultati chiave includono:
- Aumento del 112% delle visite dei pazienti rispetto all'anno precedente, servendo 36.779 pazienti
- Crescita del 218% nel numero di nuovi medici che si uniscono alla piattaforma, con 48 nuovi dottori a bordo
- Valutazione di 4,4 stelle su Google da oltre 2.400 recensioni
Il modello di Rocket Doctor consente ai medici indipendenti di operare in modo efficiente mentre sono coperti dall'assicurazione sanitaria provinciale dell'Alberta. L'azienda prevede di integrare strumenti basati sull'IA e di espandere i propri servizi in tutto il Canada. Treatment.com AI Inc. ha un accordo definitivo di acquisto di azioni datato 11 febbraio 2025, per acquisire Rocket Doctor Inc.
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF) anuncia un crecimiento significativo de la plataforma de atención médica virtual Rocket Doctor en Alberta. La plataforma ha servido a más de 71,000 albertanos, con un 35% de comunidades con menos de 25,000 habitantes.
Los logros clave incluyen:
- Aumento del 112% en las visitas de pacientes año tras año, atendiendo a 36,779 pacientes
- Crecimiento del 218% en nuevos médicos que se unen a la plataforma, con 48 nuevos doctores incorporados
- Calificación de 4.4 estrellas en Google de más de 2,400 reseñas
El modelo de Rocket Doctor permite a los médicos independientes operar de manera eficiente mientras están cubiertos por el seguro de salud provincial de Alberta. La empresa planea integrar herramientas impulsadas por IA y expandir sus servicios en todo Canadá. Treatment.com AI Inc. tiene un acuerdo definitivo de compra de acciones fechado el 11 de febrero de 2025, para adquirir Rocket Doctor Inc.
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF)는 알버타에서 Rocket Doctor의 가상 의료 플랫폼의 상당한 성장을 발표했습니다. 이 플랫폼은 71,000명 이상의 알버타 주민에게 서비스를 제공했으며, 그 중 35%는 인구 25,000명 미만의 지역 사회에서 왔습니다.
주요 성과로는:
- 전년 대비 환자 방문이 112% 증가하여 36,779명의 환자를 서비스함
- 플랫폼에 합류하는 신규 의사가 218% 성장하여 48명의 새로운 의사가 합류함
- 2,400개 이상의 리뷰에서 4.4점의 구글 평점
Rocket Doctor의 모델은 독립 의사들이 알버타의 주 건강 보험에 의해 보장받으면서 효율적으로 운영할 수 있게 합니다. 회사는 AI 기반 도구를 통합하고 캐나다 전역으로 서비스를 확장할 계획입니다. Treatment.com AI Inc.는 2025년 2월 11일자로 Rocket Doctor Inc.를 인수하기 위한 확정 주식 매입 계약을 체결했습니다.
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF) annonce une croissance significative de la plateforme de santé virtuelle Rocket Doctor en Alberta. La plateforme a servi plus de 71 000 Albertains, dont 35 % proviennent de communautés de moins de 25 000 habitants.
Les réalisations clés incluent:
- Augmentation de 112 % des visites de patients d'une année sur l'autre, servant 36 779 patients
- Croissance de 218 % des nouveaux médecins rejoignant la plateforme, avec 48 nouveaux médecins à bord
- Note de 4,4 étoiles sur Google basée sur plus de 2 400 avis
Le modèle de Rocket Doctor permet aux médecins indépendants d'opérer efficacement tout en étant couverts par l'assurance santé provinciale de l'Alberta. L'entreprise prévoit d'intégrer des outils basés sur l'IA et d'étendre ses services à travers le Canada. Treatment.com AI Inc. a un accord d'achat d'actions définitif daté du 11 février 2025, pour acquérir Rocket Doctor Inc.
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF) kündigt ein signifikantes Wachstum der virtuellen Gesundheitsplattform Rocket Doctor in Alberta an. Die Plattform hat über 71.000 Albertaner bedient, wobei 35% aus Gemeinden mit weniger als 25.000 Einwohnern stammen.
Wichtige Erfolge umfassen:
- 112% Anstieg der Patientenkontakte im Jahresvergleich, mit 36.779 bedienten Patienten
- 218% Wachstum bei neuen Ärzten, die der Plattform beitreten, mit 48 neuen Ärzten an Bord
- 4,4-Sterne-Bewertung auf Google aus über 2.400 Bewertungen
Das Modell von Rocket Doctor ermöglicht es unabhängigen Ärzten, effizient zu arbeiten, während sie durch die Provinzkrankenversicherung von Alberta abgedeckt sind. Das Unternehmen plant, KI-gestützte Tools zu integrieren und seine Dienstleistungen in ganz Kanada auszubauen. Treatment.com AI Inc. hat einen endgültigen Aktienkaufvertrag datiert auf den 11. Februar 2025, um Rocket Doctor Inc. zu erwerben.
- Strong user growth with 71,000+ patients served in Alberta
- 112% YoY increase in patient visits (36,779 patients)
- 218% YoY growth in physician adoption
- High patient satisfaction with 4.4-star rating (2,400+ reviews)
- Coverage under Alberta's provincial health insurance
- None.
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) Announces Rocket Doctor’s Growth and Expansion in Alberta, Empowering Independent Physicians and Enhancing Patient Access to Care.
●71,000+ Albertans have received care through Rocket Doctor, with
●A
●
●A 4.4-star rating on Google for Rocket Doctor with over 2,400 reviews, reflecting high patient satisfaction.
VANCOUVER, BC, March 20, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce that Rocket Doctor Inc. (“Rocket Doctor”) an entity in which Treatment proposes to acquire pursuant to a definitive share purchase agreement dated February 11, 2025, and its virtual healthcare marketplace is experiencing significant expansion in Alberta as it continues to transform access to primary and specialist care across the province.
With over 71,000 Albertans already served, including
"Alberta is facing a physician shortage, and Rocket Doctor is stepping in to bridge that gap with a scalable, sustainable solution," said Dr. William Cherniak, Founder and CEO of Rocket Doctor. "Our model supports doctors in maintaining their independence while ensuring that Albertans, whether in urban centers or rural communities, can access the high-quality healthcare they need."
Rocket Doctor’s unique approach is resonating with both patients and physicians. Unlike many virtual care platforms, which often rely on centralized corporate practice groups, Rocket Doctor equips independent doctors with the technology and an administrative support system that allows them to operate efficiently while being fully covered under Alberta’s provincial health insurance. This structure ensures better patient-doctor relationships, long-term continuity of care, and a physician-led model that aligns with Alberta’s healthcare framework.
The platform’s success is reflected in its strong reputation among patients, earning a 4.4-star rating on Google with over 2,400 reviews. As demand continues to rise, Rocket Doctor remains committed to expanding its physician network, integrating AI-driven tools, and refining its services to further improve healthcare accessibility across the province.
“More than ever, entrepreneurs are essential to Alberta's economy. Alberta Innovates is here to ensure innovators developing tech-based businesses have access to the capital, coaching, and community they need to succeed,” said Mark Summers, Interim VP Investments at Alberta Innovates Scaleup and Growth Accelerator Program. “We are proud to support companies like Rocket Doctor that are driving healthcare innovation while leveraging advanced technology in Alberta.”
A Scalable Model for the Future of Healthcare
Rocket Doctor’s physician-first model is not only addressing immediate healthcare gaps but also positioning itself as a long-term solution for healthcare sustainability. The platform’s rapid adoption by both patients and physicians signals strong market potential and investor confidence in its scalable business model.
"We are committed to leveraging technology and innovation to expand healthcare access while supporting independent physicians in delivering exceptional care," said Cherniak. "The momentum we are seeing in Alberta is just the beginning, as we continue to enhance our platform and expand across Canada."
With the continued growth, Rocket Doctor is set to further integrate AI-driven tools, strengthen its physician network, and expand its offerings to better serve patients and support Alberta’s healthcare infrastructure.
About Treatment.com AI Inc.
Treatment.com AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, Treatment.com AI has built a comprehensive, personalized healthcare AI engine — the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals as well as providing recommended tests (physical and lab), imaging and billing codes. The GLM helps healthcare professionals (doctors, nurses or pharmacists) reduce their administrative burden; creates more time for needed face-to-face patient appointments; and enables greater consistency in quality of patient support. Treatment.com AI’s GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities. To learn more about Treatment’s products and services: www.treatment.com or email: info@treatment.com
About Rocket Doctor Inc.
Rocket Doctor is a technology-driven digital health platform and marketplace that is breaking down obstacles that limit access to quality, comprehensive and cost-effective healthcare. Our proprietary software equips doctors with the tools to run successful practices in virtual and hybridized in-person/virtual models of care, enabling them to provide tailored care to patients in remote communities, particularly those in rural and Northern communities across Canada and on Medicaid in the United States. Leveraging large language models, AI/ML and wireless medical devices, Rocket Doctor is bridging the healthcare divide, connecting patients to equitable and accessible virtual healthcare services regardless of age, location, or financial status.
To learn more about Rocket Doctor's platform and services, visit www.rocketdoctor.ca (Canada) or www.rocketdoctor.io (U.S.) or email media@rocketdoctor.io.
FOR ADDITIONAL INFORMATION, CONTACT:
Dr. Essam Hamza, CEO
For media inquiries, contact: media@treatment.com
Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955
Cautionary Statement
This news release contains forward-looking statements that are based on Treatment.com AI’s expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to the adoption of Rocket Doctor’s platform and the closing of the acquisition of Rocket Doctor, as anticipated or at all, and the timing thereof. Although Treatment.com believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements, and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and Treatment.com undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law.
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
